Literature DB >> 11928805

Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.

Roberto Benelli1, Roberta Venè, Davide Bisacchi, Spiridione Garbisa, Adriana Albini.   

Abstract

Several reports have attributed to green tea chemopreventive and therapeutic properties. Epidemiological studies have linked the regular use of green tea to a reduced incidence of breast and colon carcinomas. Tea contains several antioxidants, including polyphenols of the catechin (green tea) and theaflavin (black tea) groups. Green tea derivatives have been shown to act in vitro and in vivo as anti-inflammatory, anti-viral and anti-tumor drugs. Despite the extensive body of data only few studies have investigated the molecular mechanisms underlying these effects. In this brief review we focus on the inhibitory activity of catechins derived from green tea toward proteases involved in tumor invasion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11928805     DOI: 10.1515/BC.2002.010

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  23 in total

1.  Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1.

Authors:  Matthias Dormeyer; Yvonne Adams; Bernd Kramer; Srabasti Chakravorty; Man Tsuey Tse; Stefano Pegoraro; Lisa Whittaker; Michael Lanzer; Alister Craig
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice.

Authors:  Jae-Hyung Park; Yoon Jung Choi; Yong Woon Kim; Sang Pyo Kim; Ho-Chan Cho; Shinbyoung Ahn; Ki-Cheor Bae; Seung-Soon Im; Jae-Hoon Bae; Dae-Kyu Song
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-27       Impact factor: 3.000

3.  Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Heba F Pasha; Hisham R Abdel-Aziz
Journal:  Clin Exp Med       Date:  2011-11-12       Impact factor: 3.984

4.  Mechanism of Anti-rotavirus Synergistic Activity by Epigallocatechin Gallate and a Proanthocyanidin-Containing Nutraceutical.

Authors:  S M Lipson; G Karalis; L Karthikeyan; F S Ozen; R E Gordon; S Ponnala; J Bao; W Samarrai; E Wolfe
Journal:  Food Environ Virol       Date:  2017-05-02       Impact factor: 2.778

5.  Green tea, phytic acid, and inositol in combination reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats.

Authors:  Janak Khatiwada; Martha Verghese; Shurrita Davis; Leonard L Williams
Journal:  J Med Food       Date:  2011-04-18       Impact factor: 2.786

6.  Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.

Authors:  Esther Melgarejo; Miguel Angel Medina; Francisca Sánchez-Jiménez; José Luis Urdiales
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 7.  Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases.

Authors:  Jun-ichi Suzuki; Mitsuaki Isobe; Ryuichi Morishita; Ryozo Nagai
Journal:  Mediators Inflamm       Date:  2009-07-19       Impact factor: 4.711

Review 8.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

9.  Synergistic and additive effects of epigallocatechin gallate and digitonin on Plasmodium sporozoite survival and motility.

Authors:  Janina K Hellmann; Sylvia Münter; Michael Wink; Friedrich Frischknecht
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

10.  Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats.

Authors:  Ali Akbar Abolfathi; Daryoush Mohajeri; Ali Rezaie; Mehrdad Nazeri
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.